Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Polycystic Ovary Syndrome 7Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Breast Neoplasms 3Leukoplakia, Oral 2Erythroplasia 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urothelial Cancer 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Prediabetic State 1Posterior Fossa Ependymal Tumor 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Obesity 1Neoplasms by Site 1Mouth Neoplasms 1Metabolic Diseases 1Melanoma 1Medulloblastoma 1Insulin Resistance 1Infertility 1Hyperplasia 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Drug-drug Interaction,SHR3680 1

Interventions

sugemalimab 1aldesleukin 1aflutinib 1X-Rays 1Pharmaceutical Preparations 1Metformin 1Interleukin-2 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion, Malignant × Metformin × 90 days × Clear all
NCT02122185 2026-03-27

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

University of Chicago

Phase 2 Completed
111 enrolled 15 charts
GynecologicThoracic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡